Variant report
| Variant | rs73994772 |
|---|---|
| Chromosome Location | chr17:63224049-63224050 |
| allele | C/T |
| Outlinks | Ensembl UCSC |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr17:63220600-63224400 | Weak transcription | Esophagus | oesophagus |
| 2 | chr17:63220600-63224400 | Weak transcription | Right Atrium | heart |
| 3 | chr17:63221400-63224200 | Weak transcription | Ovary | ovary |
| 4 | chr17:63221600-63228000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
| 5 | chr17:63222400-63224800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
| 6 | chr17:63222600-63224800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
| 7 | chr17:63222800-63224400 | Weak transcription | Fetal Lung | lung |
| 8 | chr17:63223400-63224600 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
| 9 | chr17:63223400-63225400 | Enhancers | Spleen | Spleen |
| 10 | chr17:63223600-63224400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
| 11 | chr17:63223600-63224400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
| 12 | chr17:63223600-63225400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
| 13 | chr17:63223800-63224400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
| 14 | chr17:63223800-63225200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
| 15 | chr17:63223800-63226200 | Enhancers | Primary hematopoietic stem cells | blood |
| 16 | chr17:63224000-63224200 | Enhancers | Lung | lung |
| 17 | chr17:63224000-63224400 | Bivalent Enhancer | Primary hematopoietic stem cells short term culture | blood |
| 18 | chr17:63224000-63225200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
| 19 | chr17:63224000-63226400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
